September 2014 New Urology Products: iPad app works with genomic test to plot post-prostatectomy care
iPad app works with genomic test to plot post-prostatectomy care
Austin, TX—The Decipher Portal Professional iPad app is designed to educate physicians on the optimal post-prostatectomy course of action for individual prostate cancer patients. Developed by Visible Health and launched by GenomeDx Biosciences, the app works in tandem with GenomeDx’s Decipher genomic test that uses the expression of 22 RNA biomarkers to calculate the probability of metastasis within 5 years of prostatectomy. A recent study showed 31% of treatment recommendations changed with knowledge of genomic classifiers.
For more information, visit www.visiblehealth.com.
Generic version of testosterone gel launched under new partnership
Chesterbrook, PA—Auxilium Pharmaceuticals, Inc. has partnered with Prasco, LLC to introduce an authorized generic version of Testim (testosterone gel). Testim and its authorized generic version are testosterone gels approved by the FDA for the treatment of adult males with low or no testosterone. Auxilium will maintain responsibility for the manufacture of Testim and the generic gel, as well as for the distribution of branded Testim. Prasco has begun shipping the product.
For more information, visit www.auxilium.com.
More urology products